By analyzing the effects of Acer3 knockout or ACER3 knockdown on the metabolism of ceramides in hepatocytes, we found that ACER3 upregulation prevents the buildup of the C18:1-ceramide in diet-induced NASH livers and palmitic-acid-treated hepatocytes. Here, ACER3 is linked to metabolic dysfunction-associated steatohepatitis.